top of page

Tagrisso (Osimertinib) is used for the 1st-line treatment of patients with metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).

Manufacturer :  AstraZeneca

TAGRISSO OSIMERTINIB 40MG & 80MG TABLET

0,00₹Precio
  • 30 x 1 tablets

bottom of page